Basics |
Company: |
Sana Biotechnology, Inc. |
IPO Date: |
February 1, 2021 |
Sector: |
Healthcare |
Industry: |
Biotech |
Market Cap: |
$672.04M |
Activated in VL: |
True |
Average Daily Range |
Avg Daily Range: |
$0.39 | 4.15%
|
Avg Daily Range (30 D): |
$0.26 | 6.97%
|
Avg Daily Range (90 D): |
$0.17 | 5.25%
|
Institutional Daily Volume |
Avg Daily Volume: |
1.39M |
Avg Daily Volume (30 D): |
10.53M |
Avg Daily Volume (90 D): |
4.5M |
Trade Size |
Avg Trade Size (Sh.): |
119 |
Avg Trade Size (Sh.) (30 D): |
213 |
Avg Trade Size (Sh.) (90 D): |
192 |
Institutional Trades |
Total Inst.Trades: |
1,152 |
Avg Inst. Trade: |
$1.96M |
Avg Inst. Trade (30 D): |
$1.09M |
Avg Inst. Trade (90 D): |
$.97M |
Avg Inst. Trade Volume: |
.22M |
Avg Inst. Trades (Per Day): |
1 |
Market Closing Trades |
Avg Closing Trade: |
$2.1M |
Avg Closing Trade (30 D): |
$.95M |
Avg Closing Trade (90 D): |
$.9M |
Avg Closing Volume: |
244.26K |
|
|
|
|
Financials |
|
TTM |
Q3 2024 |
Q2 2024 |
Basic EPS
|
$-1.4
|
$-.25
|
$-.21
|
Diluted EPS
|
$-1.4
|
$-.25
|
$-.21
|
Revenue
|
$ M
|
$ M
|
$ M
|
Gross Profit
|
$
|
$
|
$
|
Net Income / Loss
|
$ -305.81M
|
$ -59.92M
|
$ -50.29M
|
Operating Income / Loss
|
$ -312.48M
|
$ -61.76M
|
$ -49.37M
|
Cost of Revenue
|
$
|
$
|
$
|
Net Cash Flow
|
$ -41.45M
|
$ -7.96M
|
$ -42.1M
|
PE Ratio
|
|
|
|
|